Article
SLC17A2 Expression Correlates with Prognosis and Immune Infiltrates in Hepatocellular Carcinoma
2021-06-07
Abstract excerpt
<h4>Background: </h4> Hepatocellular carcinoma (HCC) is one of the most common malignant tumors with a dismal prognosis according to updated statistics. At present, there are many deficiencies in targeted therapy for liver cancer. The solute carrier family 17 member 2 (SLC17A2) has not been studied in liver cancer, therefore, we evaluate the role of SLC17A2 in HCC by bioinformatics analysis. <h4>Methods: </h4>: Th...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 214dd852-18c5-5cec-9370-33c612356a38
- DOI
- 10.21203/rs.3.rs-573999/v1
